Cigarette smoking and PM2.5 might jointly exacerbate the risk of metabolic syndrome

Hao-Hung Tsai1,2,3,4,5, Disline Manli Tantoh3,6, Wen Yu Lu6

  • 1Institute of Medicine, Chung Shan Medical University, Taichung City, Taiwan.

PubMed
Abstract

Insights

Cigarette smoking and fine particulate matter (PM2.5) independently increase metabolic syndrome (MS) risk. Combined exposure significantly elevates MS risk, with current smokers facing the highest odds, especially with high PM2.5 levels.

Area of Science:

  • Environmental Health
  • Cardiovascular Disease Epidemiology
  • Metabolic Syndrome Research

Background:

  • Cigarette smoking and fine particulate matter (PM2.5) are significant contributors to cardiovascular morbidity and mortality.
  • The combined impact of PM2.5 and cigarette smoking on metabolic syndrome (MS) development remains unclear.

Purpose of the Study:

  • To investigate the independent and joint associations of PM2.5 exposure and cigarette smoking with the risk of developing metabolic syndrome (MS) in Taiwanese adults.

Main Methods:

  • A large-scale study of 126,366 Taiwanese adults aged 30-70 without a cancer history.
  • Data on metabolic syndrome, smoking status, and covariates were sourced from the Taiwan Biobank (TWB).
  • PM2.5 exposure levels were obtained from the Environmental Protection Administration (EPA), Taiwan, and categorized into quartiles.

Main Results:

  • Both PM2.5 exposure and cigarette smoking were significantly associated with an increased risk of MS.
  • Higher PM2.5 levels demonstrated a dose-dependent increase in MS risk.
  • Current smokers exhibited a substantially higher risk of MS compared to nonsmokers, with a synergistic effect observed when combined with high PM2.5 exposure.

Conclusions:

  • PM2.5 and cigarette smoking are independent risk factors for MS.
  • Cigarette smoking appears to have a more pronounced effect on MS risk than PM2.5 exposure.
  • Concurrent exposure to both PM2.5 and cigarette smoking significantly compounds the risk of developing MS.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.8K
Stress Prevention and Stress Management Techniques IV01:26

Stress Prevention and Stress Management Techniques IV

Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
29
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Stimulants01:29

Stimulants

Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
197
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
274
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K